Literature DB >> 18614301

Neurological examination of preterm infants at term equivalent age.

Daniela Ricci1, Domenico M M Romeo, Leena Haataja, Ingrid C van Haastert, Laura Cesarini, Jonna Maunu, Marika Pane, Francesca Gallini, Rita Luciano, Costantino Romagnoli, Linda S de Vries, Frances M Cowan, Eugenio Mercuri.   

Abstract

BACKGROUND: We previously reported the neurological findings of the Dubowitz neonatal examination in a cohort of 157 low-risk preterms born between 25 and 33 weeks gestational age (GA) and examined at term equivalent age (TEA). Median and range of scores were wider than those found in term-born infants and preterms showed a different neurological behaviour in specific items. However, the cohort number was too small to draw any definitive conclusion about the distribution of findings. AIMS: We provide normative data from a low-risk cohort of 380 preterm infants; we also assess the findings and their relationship to motor outcome in preterms with major cranial ultrasound (US) abnormality. STUDY
DESIGN: We assessed, at TEA, 380 low-risk preterms born <35 weeks gestation (range 25-34.9, median 29) with normal 2 year motor outcome and 85 preterm infants with major US abnormality.
RESULTS: At TEA low-risk preterms had less flexor limb tone, poorer head control but better visual following than term-born infants. For 28/34 of the neurological items the range and median scores were similar across gestational ages. In infants with major US lesions the range and median scores differed from low-risk preterms in 20/34 items; 40% of infants developing a diplegia and 80% developing a tetraplegia had >7 items outside the 90th centile; all infants with >12 items outside the 90th centile developed a tetraplegia.
CONCLUSIONS: We provide reference values for the neurological examination of low-risk preterms at TEA. In infants with major US abnormality the number of items outside the 90th centile was an indicator of outcome severity.

Entities:  

Mesh:

Year:  2008        PMID: 18614301     DOI: 10.1016/j.earlhumdev.2008.05.007

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  6 in total

1.  Combined predictors of neurodevelopment in very low birth weight preterm infants.

Authors:  Pilar Medina-Alva; Kevin R Duque; Alonso Zea-Vera; Sicilia Bellomo; César Cárcamo; Daniel Guillen-Pinto; Maria Rivas; Alfredo Tori; Jaime Zegarra; Luis Cam; Anne Castañeda; Aasith Villavicencio; Theresa J Ochoa
Journal:  Early Hum Dev       Date:  2019-02-08       Impact factor: 2.079

2.  Early prediction of cerebral palsy after neonatal intensive care using motor development trajectories in infancy.

Authors:  Nathalie L Maitre; James C Slaughter; Judy L Aschner
Journal:  Early Hum Dev       Date:  2013-07-12       Impact factor: 2.079

3.  Profile of minor neurological findings after perinatal asphyxia.

Authors:  Anna Kivi; Marjo Metsäranta; Sanna Toiviainen-Salo; Sampsa Vanhatalo; Leena Haataja
Journal:  Acta Paediatr       Date:  2021-11-17       Impact factor: 4.056

4.  PPREMO: a prospective cohort study of preterm infant brain structure and function to predict neurodevelopmental outcome.

Authors:  Joanne M George; Roslyn N Boyd; Paul B Colditz; Stephen E Rose; Kerstin Pannek; Jurgen Fripp; Barbara E Lingwood; Melissa M Lai; Annice H T Kong; Robert S Ware; Alan Coulthard; Christine M Finn; Sasaka E Bandaranayake
Journal:  BMC Pediatr       Date:  2015-09-16       Impact factor: 2.125

5.  Body Posture Asymmetry in Prematurely Born Children at Six Years of Age.

Authors:  Katarzyna Walicka-Cupryś; Justyna Drzał-Grabiec; Maciej Rachwał; Paweł Piwoński; Lidia Perenc; Łukasz Przygoda; Katarzyna Zajkiewicz
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

6.  Assessing the Utility of Neonatal Screening Assessments in Early Diagnosis of Cerebral Palsy in Preterm Infants.

Authors:  Rebecca Connors; Vathana Sackett; Catherine Machipisa; Kenneth Tan; Pramod Pharande; Lindsay Zhou; Atul Malhotra
Journal:  Brain Sci       Date:  2022-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.